Mycobacterium tuberculosis Lipoprotein MPT83 Induces Apoptosis of Infected Macrophages by Activating the TLR2/p38/COX-2 Signaling Pathway

The Journal of Immunology : Official Journal of the American Association of Immunologists
Lin WangBaoxue Ge

Abstract

Tuberculosis caused by Mycobacterium tuberculosis continues to pose a serious global health threat. The attenuated Mycobacterium bovis bacillus Calmette-Guérin, as the only licensed vaccine, has limited protective efficacy against TB. The development of more effective antituberculosis vaccines is urgent and demands for further identification and understanding of M. tuberculosis Ags. MPT83 (Rv2873), a secreted mycobacterial lipoprotein, has been applied into subunit vaccine development and shown protective effects against M. tuberculosis infection in animals; however, the understanding of the underlying mechanism is limited. In present study, we systematically studied the effect of MPT83 on macrophage apoptosis by constructing Mycobacterium smegmatis strain overexpressing MPT83 (MS_MPT83) and purifying rMPT83 protein. We found that MPT83 induced apoptosis in both human and mouse macrophages. MPT83 induced cyclooxygenase-2 (COX-2) expression at both the transcriptional and protein levels in macrophages, whereas silencing or inhibiting COX-2 blocked rMPT83-induced apoptosis or the enhanced apoptotic response to MS_MPT83 in comparison with M. smegmatis transfected with pMV261 vector (MS_Vec), indicating that COX-2 is required for M...Continue Reading

References

May 16, 2002·International Immunopharmacology·Bianca Rocca, Garret A FitzGerald
Jul 23, 2003·Nature Medicine·Ulrich E SchaibleStefan H E Kaufmann
Oct 12, 2004·Annual Review of Cell and Developmental Biology·Isabelle VergneVojo Deretic
Jan 18, 2006·Immunity·Florian WinauUlrich E Schaible
Jul 31, 2007·PLoS Pathogens·Kamalakannan VelmuruganVolker Briken
Aug 3, 2007·The Journal of Clinical Investigation·Joseph HincheySteven A Porcelli
Jun 30, 2009·Nature Immunology·Maziar DivangahiHeinz G Remold
Jul 14, 2010·Nature Immunology·Maziar DivangahiSamuel M Behar
Dec 17, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Su-Ting ChenHong Cai
Jun 14, 2013·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Tomoyasu NishimuraHeinz G Remold
Apr 23, 2014·Proceedings of the National Academy of Sciences of the United States of America·Olga DanilchankaMichael Niederweis
Dec 3, 2014·Seminars in Immunology·Andrew H Moraco, Hardy Kornfeld
May 23, 2015·Future Microbiology·Khalid Hussain Bhat, Sangita Mukhopadhyay
Aug 4, 2015·Nature Structural & Molecular Biology·Jim SunMichael Niederweis
Sep 18, 2015·Lancet·Keertan DhedaGary Maartens

❮ Previous
Next ❯

Citations

Mar 20, 2020·Pathogens·Abualgasim Elgaili AbdallaMohammed Alsadig Mousa
Mar 16, 2021·Frontiers in Cellular and Infection Microbiology·Yingying LeiGang Cao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.